Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Hansen

Showing results (61-70 of 183) with videos related to

Pageof 19
Sort By:
Journal of the American Pharmacists Association : Japha|September 25, 2021
Individuals' preference for financial over social incentives for medication adherenceRuth Jeminiwa, Natalie S Hohmann, Tessa J Hastings, et al.
Inflammatory Bowel Diseases|May 15, 2023
YouTube as a Source of Information for Food, Diet-Related Items, and Advisory Comments for the Management of Inflammatory Bowel DiseaseKonstantinos Gkikas, Mhairi Wan, Vaios Svolos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2010
Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancerBing Li, Yihua Cai, Chunjian Qi, et al.
Expert Opinion on Drug Safety|December 22, 2018
Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)Shahariar Mohammed Fahim, Ahmed Ullah Mishuk, Ning Cheng, et al.
FEMS Immunology and Medical Microbiology|October 20, 2010
Could Helicobacter organisms cause inflammatory bowel disease?Richard Hansen, John M Thomson, James G Fox, et al.
Journal of Managed Care & Specialty Pharmacy|February 28, 2018
The Association Between Patient Sociodemographic Characteristics and Generic Drug Use: A Systematic Review and Meta-analysisAhmed U Mishuk, Jingjing Qian, Jennifer N Howard, et al.
Gastroenterology|December 23, 2025
The Gut Microbiome at the Onset of Inflammatory Bowel Disease: A Systematic Review and Unified Bioinformatic SynthesisPeter Rimmer, Fan Zhang, Gregor Scott, et al.
Inflammatory Bowel Diseases|September 25, 2024
Pediatric Inflammatory Bowel Disease Type Unclassified: A Nationwide Cohort Study in Scotland With up to 20 Years Follow-up Shows Reclassification in the Majority and Mild Course in Those Whose Diagnosis Is UnchangedDavid I F Wands, Laura Gianolio, Fiona Cameron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathwayBing Li, Daniel J Allendorf, Richard Hansen, et al.
Clinical Immunology (Orlando, Fla.)|June 19, 2007
Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathwaysBing Li, Daniel Cramer, Stephanie Wagner, et al.
Pageof 19

Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
Journal of the American Pharmacists Association : Japha|September 25, 2021
Individuals' preference for financial over social incentives for medication adherenceRuth Jeminiwa, Natalie S Hohmann, Tessa J Hastings, et al.
Inflammatory Bowel Diseases|May 15, 2023
YouTube as a Source of Information for Food, Diet-Related Items, and Advisory Comments for the Management of Inflammatory Bowel DiseaseKonstantinos Gkikas, Mhairi Wan, Vaios Svolos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2010
Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancerBing Li, Yihua Cai, Chunjian Qi, et al.
Expert Opinion on Drug Safety|December 22, 2018
Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)Shahariar Mohammed Fahim, Ahmed Ullah Mishuk, Ning Cheng, et al.
FEMS Immunology and Medical Microbiology|October 20, 2010
Could Helicobacter organisms cause inflammatory bowel disease?Richard Hansen, John M Thomson, James G Fox, et al.
Journal of Managed Care & Specialty Pharmacy|February 28, 2018
The Association Between Patient Sociodemographic Characteristics and Generic Drug Use: A Systematic Review and Meta-analysisAhmed U Mishuk, Jingjing Qian, Jennifer N Howard, et al.
Gastroenterology|December 23, 2025
The Gut Microbiome at the Onset of Inflammatory Bowel Disease: A Systematic Review and Unified Bioinformatic SynthesisPeter Rimmer, Fan Zhang, Gregor Scott, et al.
Inflammatory Bowel Diseases|September 25, 2024
Pediatric Inflammatory Bowel Disease Type Unclassified: A Nationwide Cohort Study in Scotland With up to 20 Years Follow-up Shows Reclassification in the Majority and Mild Course in Those Whose Diagnosis Is UnchangedDavid I F Wands, Laura Gianolio, Fiona Cameron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathwayBing Li, Daniel J Allendorf, Richard Hansen, et al.
Clinical Immunology (Orlando, Fla.)|June 19, 2007
Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathwaysBing Li, Daniel Cramer, Stephanie Wagner, et al.
Pageof 19